Related Experiment Videos
[Multi-systemic toxicity of colchicine and renal failure: apropos of a case]
L Rosset1, E Descombes, G Fellay
1Clinique de médecine interne, Hôpital cantonal, Fribourg.
Schweizerische Medizinische Wochenschrift
|January 15, 1999
Abstract:
The use of colchicine can produce various side effects, but multiorgan toxicity is rare. We report the first Swiss case of multiorgan toxicity involving typical neuromuscular lesions. Muscular biopsy is a valuable tool in confirming the diagnosis. Renal insufficiency and hepatobiliary diseases are predisposing factors for such complications. Colchicine pharmacology in the case of renal insufficiency is discussed.
Insights
Colchicine can cause rare multiorgan toxicity, especially with kidney or liver issues. Muscular biopsy aids diagnosis in this rare complication.
Area of Science:
- Toxicology
- Pharmacology
- Neurology
Background:
- Colchicine is a medication used for gout and other inflammatory conditions.
- While generally safe, colchicine can cause side effects.
- Multiorgan toxicity from colchicine is an uncommon but serious adverse event.
Observation:
- This report details the first documented case of colchicine-induced multiorgan toxicity in Switzerland.
- The patient presented with significant neuromuscular lesions.
- The case highlights the potential for severe colchicine side effects.
Findings:
- Multiorgan toxicity, including neuromuscular lesions, is a rare but possible side effect of colchicine.
- Muscular biopsy is an effective diagnostic tool for identifying colchicine-induced neuromuscular damage.
- Renal insufficiency and hepatobiliary diseases are identified as key predisposing factors for this toxicity.
Implications:
- Understanding colchicine pharmacology in patients with renal insufficiency is crucial for safe prescribing.
- Early recognition and diagnosis, potentially aided by muscular biopsy, are important for managing colchicine toxicity.
- This case underscores the need for vigilance regarding colchicine side effects, particularly in patients with pre-existing organ dysfunction.